Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)

Clinical trial NCT00129740 · COMPLETED

Trial details

NCT number: NCT00129740
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myelogenous, Chronic

Start date: 2005-06-27
Primary completion: 2018-07-11
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.